205 related articles for article (PubMed ID: 27307214)
1. The effect of superparamagnetic iron oxide nanoparticles surface engineering on relaxivity of magnetoliposome.
Khaleghi S; Rahbarizadeh F; Ahmadvand D; Malek M; Madaah Hosseini HR
Contrast Media Mol Imaging; 2016 Sep; 11(5):340-349. PubMed ID: 27307214
[TBL] [Abstract][Full Text] [Related]
2. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging.
Chee HL; Gan CRR; Ng M; Low L; Fernig DG; Bhakoo KK; Paramelle D
ACS Nano; 2018 Jul; 12(7):6480-6491. PubMed ID: 29979569
[TBL] [Abstract][Full Text] [Related]
3. Citric acid coated ultrasmall superparamagnetic iron oxide nanoparticles conjugated with lactoferrin for targeted negative MR imaging of glioma.
Xiao R; Ding J; Chen J; Zhao Z; He L; Wang H; Huang S; Luo B
J Biomater Appl; 2021 Jul; 36(1):15-25. PubMed ID: 33287646
[TBL] [Abstract][Full Text] [Related]
4. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
[TBL] [Abstract][Full Text] [Related]
5. Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells.
Zhang Q; Rajan SS; Tyner KM; Casey BJ; Dugard CK; Jones Y; Paredes AM; Clingman CS; Howard PC; Goering PL
J Biomed Mater Res B Appl Biomater; 2016 Jul; 104(5):1032-42. PubMed ID: 26013845
[TBL] [Abstract][Full Text] [Related]
6. Relaxivities of magnetoliposomes: the effect of cholesterol.
Carvalho A; Gonçalves MC; Martins MB; Meixedo D; Feio G
Magn Reson Imaging; 2013 May; 31(4):610-2. PubMed ID: 23333578
[TBL] [Abstract][Full Text] [Related]
7. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.
Chen TJ; Cheng TH; Chen CY; Hsu SC; Cheng TL; Liu GC; Wang YM
J Biol Inorg Chem; 2009 Feb; 14(2):253-60. PubMed ID: 18975017
[TBL] [Abstract][Full Text] [Related]
8. Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages.
Saito S; Tsugeno M; Koto D; Mori Y; Yoshioka Y; Nohara S; Murase K
Int J Nanomedicine; 2012; 7():5415-21. PubMed ID: 23091384
[TBL] [Abstract][Full Text] [Related]
9. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
[TBL] [Abstract][Full Text] [Related]
10. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
[TBL] [Abstract][Full Text] [Related]
11. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles.
Amiri H; Bordonali L; Lascialfari A; Wan S; Monopoli MP; Lynch I; Laurent S; Mahmoudi M
Nanoscale; 2013 Sep; 5(18):8656-65. PubMed ID: 23896964
[TBL] [Abstract][Full Text] [Related]
12. Tripod USPIONs with high aspect ratio show enhanced T2 relaxation and cytocompatibility.
Wyss PP; Lamichhane S; Rauber M; Thomann R; Krämer KW; Shastri VP
Nanomedicine (Lond); 2016 May; 11(9):1017-30. PubMed ID: 26983681
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
[TBL] [Abstract][Full Text] [Related]
14. Iron oxide nanoparticles as positive T
Oberdick SD; Jordanova KV; Lundstrom JT; Parigi G; Poorman ME; Zabow G; Keenan KE
Sci Rep; 2023 Jul; 13(1):11520. PubMed ID: 37460669
[TBL] [Abstract][Full Text] [Related]
15. Co-precipitation of DEAE-dextran coated SPIONs: how synthesis conditions affect particle properties, stem cell labelling and MR contrast.
Barrow M; Taylor A; García Carrión J; Mandal P; Park BK; Poptani H; Murray P; Rosseinsky MJ; Adams DJ
Contrast Media Mol Imaging; 2016 Sep; 11(5):362-370. PubMed ID: 27358113
[TBL] [Abstract][Full Text] [Related]
16. Improved specific loss power on cancer cells by hyperthermia and MRI contrast of hydrophilic Fe
Hoque SM; Huang Y; Cocco E; Maritim S; Santin AD; Shapiro EM; Coman D; Hyder F
Contrast Media Mol Imaging; 2016 Nov; 11(6):514-526. PubMed ID: 27659164
[TBL] [Abstract][Full Text] [Related]
17. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
[TBL] [Abstract][Full Text] [Related]
18. USPIO-loaded red blood cells as a biomimetic MR contrast agent: a relaxometric study.
Boni A; Ceratti D; Antonelli A; Sfara C; Magnani M; Manuali E; Salamida S; Gozzi A; Bifone A
Contrast Media Mol Imaging; 2014; 9(3):229-36. PubMed ID: 24700750
[TBL] [Abstract][Full Text] [Related]
19. Individually Stabilized, Superparamagnetic Nanoparticles with Controlled Shell and Size Leading to Exceptional Stealth Properties and High Relaxivities.
Lassenberger A; Scheberl A; Stadlbauer A; Stiglbauer A; Helbich T; Reimhult E
ACS Appl Mater Interfaces; 2017 Feb; 9(4):3343-3353. PubMed ID: 28071883
[TBL] [Abstract][Full Text] [Related]
20. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity.
Tong S; Hou S; Zheng Z; Zhou J; Bao G
Nano Lett; 2010 Nov; 10(11):4607-13. PubMed ID: 20939602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
